Earnings report 📈 Stocks 🌍 United States

Aveanna Healthcare Q3 Revenue Hits $695.5 Million, Raises 2026 Guidance

Aveanna Healthcare posted a significant profit increase to $45.5 million in Q3 and raised its full-year 2026 outlook, citing strong momentum across its home care business segments.

📅 November 12, 2026 🕐 1 min read

1 assets impacted (Stocks). Net bias: 1 Bullish, 0 Bearish, 0 Neutral. Strongest signal: AVAH ↑ 7/10 (85% confidence).

📊 Affected Assets (1)

AVAH

Bullish 🤖 85%

📅 Short-term 🌍 US · Explicit

Third-quarter revenue rose 11.8% to $695.5 million and Adjusted EBITDA jumped 25.0% to $100.1 million, while quarterly net income more than tripled to $45.5 million from $14.1 million a year ago. On top of the beat, management raised full-year 2026 revenue and Adjusted EBITDA guidance, citing confidence in the outlook. A guidance increase combined with sharply higher profitability is a clear positive that typically moves the stock on the day.

Catalysts

▲ Q3 2026 revenue of $695.5 million, up 11.8% year-over-year
▲ Q3 Adjusted EBITDA of $100.1 million, up 25.0% year-over-year

Risk Factors

▼ Nine-month gross margin percentage slipped to 32.3% from 33.7% a year earlier
▼ No net income guidance provided due to volatile inputs such as interest rate cap fair value adjustments

🧭 Full analysis of these assets

🎯 Key Takeaways

Q3 revenue reached $695.5 million, an 11.8% increase compared to the same period in 2025.
Adjusted EBITDA rose 25.0% to $100.1 million for the quarter ended October 3, 2026.
Net income more than tripled to $45.5 million from $14.1 million in the prior-year period.
Management raised full-year 2026 revenue and Adjusted EBITDA guidance following strong performance.
Nine-month gross margin percentage declined to 32.3% from 33.7% in the same period last year.

📝 Executive Summary

Aveanna Healthcare Holdings reported strong third-quarter results, with revenue rising 11.8% to $695.5 million and Adjusted EBITDA jumping 25.0% to $100.1 million. Driven by organic growth across all segments, the company raised its full-year 2026 revenue and Adjusted EBITDA guidance.

❓ FAQ

Why is this good for Aveanna's stock?

The company reported a large year-over-year jump in profit — net income of $45.5 million versus $14.1 million a year ago — and 25.0% Adjusted EBITDA growth, and it explicitly raised its full-year 2026 revenue and Adjusted EBITDA guidance, signaling better-than-expected outlook.

Did the company give any cautionary signals?

Yes. The nine-month gross margin percentage declined to 32.3% from 33.7%, and the company is not providing net income guidance because of volatility in items like fair value adjustments on its interest rate caps.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article